TC
MRK icon

Titleist Capital’s Merck MRK Stock Holding History

Titleist Capital’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$360K Sell
3,242
-265
-8% -$27.1K 0.08% 169
2022
Q3 		$302K Sell
3,507
-195
-5% -$17.4K 0.07% 177
2022
Q2 		$338K Sell
3,702
-444
-11% -$39.4K 0.08% 170
2022
Q1 		$340K Buy
4,146
+677
+20% +$53.4K 0.07% 184
2021
Q4 		$266K Buy
+3,469
New +$276K 0.05% 194

Other funds holding MRK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AWA
Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Titleist Capital's MRK Position: Q4 2022 in Review

Titleist Capital reduced its Merck (MRK) stake by 7.6% in Q4 2022, selling an estimated $27.1K and leaving 3,242 shares worth $360K. The position accounts for 0.08% of the portfolio, ranked #169.

Titleist Capital first reported a position in MRK in Q4 2021 and has held it in 5 quarters since. 3,235 funds tracked by Wall St. Rank hold MRK as of Q4 2022.

  • Titleist Capital held 3,242 shares of Merck worth $360K as of Q4 2022.
  • Titleist Capital sold 265 Merck shares in Q4 2022, an estimated $27.1K.
  • Merck made up 0.08% of Titleist Capital's portfolio in Q4 2022, its #169 holding.
  • Titleist Capital first reported a position in Merck in Q4 2021 and has held it in 5 quarters since.
  • 3,235 funds tracked by Wall St. Rank held Merck as of Q4 2022.

Based on Titleist Capital's 13F filing for Q4 2022, filed 12 Jan 2023.